carbenoxolone sodium has been researched along with brefeldin a in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blum, AE; Dubyak, GR; Joseph, SM; Przybylski, RJ | 1 |
| Alberti, GS; Alvarez, CL; Davio, C; de Tezanos Pinto, F; Espelt, MV; Incicco, J; Leal Denis, MF; Schwarzbaum, PJ | 1 |
| Fry, CH; Montgomery, B; Roberts, M; Sui, G; Wu, C; Wu, R | 1 |
3 other study(ies) available for carbenoxolone sodium and brefeldin a
| Article | Year |
|---|---|
Rho-family GTPases modulate Ca(2+) -dependent ATP release from astrocytes.
Topics: Adenosine Triphosphate; ADP Ribose Transferases; Antigens, CD; Apyrase; Astrocytes; Bacterial Proteins; Bacterial Toxins; Botulinum Toxins; Brefeldin A; Calcium; Carbachol; Carbenoxolone; Cell Line; Cell Membrane Permeability; Humans; Receptor, Muscarinic M3; Receptor, PAR-1; Receptors, Lysophosphatidic Acid; rho GTP-Binding Proteins; Secretory Vesicles; Thrombin | 2008 |
On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cells.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Azo Compounds; Brefeldin A; Carbenoxolone; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Size; Exocytosis; Humans; Hypotonic Solutions; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Protein Synthesis Inhibitors; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2 | 2013 |
Purinergic and muscarinic modulation of ATP release from the urothelium and its paracrine actions.
Topics: Adenosine Triphosphate; Aged; Aging; Animals; Brefeldin A; Calcium; Carbachol; Carbenoxolone; Exocytosis; Gap Junctions; Guinea Pigs; Humans; Intestinal Mucosa; Male; Middle Aged; Muscarinic Agonists; Muscarinic Antagonists; Muscle Contraction; Paracrine Communication; Purinergic P2Y Receptor Agonists; Receptor, Muscarinic M2; Receptors, Purinergic P2Y; Uridine Triphosphate; Urothelium | 2014 |